Rösch W, Liebregts T, Gundermann K-J, Vinson B, Holtmann G
Medical Department, North West Hospital, Frankfurt, Germany.
Phytomedicine. 2006;13 Suppl 5:114-21. doi: 10.1016/j.phymed.2006.03.022. Epub 2006 Sep 15.
Functional gastrointestinal disorders such as functional (or non-ulcer) dyspepsia are characterized by a broad spectrum of symptoms referred to the upper abdomen without a detectable cause utilizing routine diagnostic measures. It is now believed that disordered gut function (including abnormalities like disturbances of motility such as postprandial fundic relaxation, gastric emptying and disturbed visceral sensory function) play a key role for the manifestation of these disorders. The underlying pathophysiology is not yet fully understood. However, the available data suggest that a number of factors may contribute to the manifestation of symptoms. These factors include environmental factors such as acute infections as trigger event, psychological stressors that may precede acute exacerbations and a genetic predisposition. Considering the large number of mechanisms, a treatment targeting a single mechanism is unlikely to be effective in all patients. Indeed, chemically defined treatments usually gain a 10-15% superiority over placebo. In recent years placebo-controlled studies have demonstrated superiority of a commercial multicomponent herbal preparation, STW 5, with the trade name Iberogast, for the treatment of patients with functional dyspepsia and irritable bowel syndrome. This phytopharmacon is a combination of nine plant extracts each with a number of different active constituents. Pharmacological studies have shown different effects of the single plant extracts on the (molecular) mechanisms which are discussed as underlying the manifestation of symptoms. Various well-controlled clinical trials have independently confirmed clinical efficacy and safety. The clinically efficacy of this multicomponent herbal preparation questions the current trend of highly targeted drug molecules that usually target one single receptor population while it has not been shown that a single receptor group plays a pivotal role for the control of symptoms. Herbal medicines are obtained from various plants and contain complex extracts with a large number of different active substances. While there are only limited head-to-head comparisons with conventional chemically defined medications, the combination of extracts with various gastrointestinal active ingredients appears to be advantageous for a heterogeneous condition such as functional dyspepsia.
功能性胃肠疾病,如功能性(或非溃疡性)消化不良,其特征是上腹部出现一系列症状,而采用常规诊断方法却找不到可检测到的病因。现在人们认为,肠道功能紊乱(包括诸如餐后胃底松弛、胃排空等运动功能障碍以及内脏感觉功能紊乱等异常情况)在这些疾病的表现中起关键作用。其潜在的病理生理学尚未完全明了。然而,现有数据表明,一些因素可能导致症状的出现。这些因素包括环境因素,如作为触发事件的急性感染、急性加重之前可能出现的心理压力源以及遗传易感性。鉴于机制众多,针对单一机制的治疗不太可能对所有患者都有效。事实上,化学定义明确的治疗通常比安慰剂有10%至15%的优势。近年来,安慰剂对照研究表明,一种商业多成分草药制剂STW 5(商品名为伊贝戈斯特)在治疗功能性消化不良和肠易激综合征患者方面具有优势。这种植物药是九种植物提取物的组合,每种提取物都含有多种不同的活性成分。药理学研究表明,单一植物提取物对被认为是症状表现基础的(分子)机制有不同影响。各种严格对照的临床试验已独立证实了其临床疗效和安全性。这种多成分草药制剂的临床疗效对当前高度靶向药物分子的趋势提出了质疑,这些药物分子通常针对单一受体群体,而尚未表明单一受体组对症状的控制起关键作用。草药源自各种植物,含有复杂的提取物,其中有大量不同的活性物质。虽然与传统化学定义明确的药物进行的直接比较有限,但含有各种胃肠道活性成分的提取物组合对于功能性消化不良这种异质性病症似乎具有优势。